Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Anai

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|August 17, 2022
Trends in primary treatment for localized prostate cancer according to the availability of treatment modalities and the impact of introducing robotic surgeryShunta Hori, Yasushi Nakai, Mitsuru Tomizawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2015
Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single instituteMakito Miyake, Daisuke Gotoh, Keiji Shimada, et al.
The Prostate|March 6, 2023
Quality of life in patients who underwent robot-assisted radical prostatectomy compared with those who underwent low-dose-rate brachytherapyYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
Urologia Internationalis|August 25, 2010
Clinical significance of heme oxygenase-1 expression in non-muscle-invasive bladder cancerMakito Miyake, Kiyohide Fujimoto, Satoshi Anai, et al.
Oncology Reports|June 3, 2015
Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinomaKiyohiko Hotta, Masayuki Sho, Kiyohide Fujimoto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 27, 2017
URETHROPLASTY FOR COMPLICATED ANTERIOR URETHRAL STRICTURESKatsuya Aoki, Shunta Hori, Yosuke Morizawa, et al.
IJU Case Reports|August 4, 2020
Localized prostate cancer with pelvic arteriovenous malformation treated with low-dose-rate brachytherapy after transcatheter embolization: Two case reportsTakuya Owari, Nobumichi Tanaka, Yasushi Nakai, et al.
Journal of Cardiology Cases|March 13, 2023
Diffuse alveolar hemorrhage and acute eosinophilic pneumonia: A rare form of amiodarone pulmonary toxicity diagnosed by bronchoalveolar lavageSatoshi Anai, Yuri Nakayama, Hiroki Gushiken, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2021
Trends in risk classification at diagnosis and choice of primary therapy for prostate cancer: An analysis of 10 839 patients from the Nara Urological Research and Treatment Group registry between 2004 and 2015Yasushi Nakai, Nobumichi Tanaka, Tomomi Fujii, et al.
In Vivo (Athens, Greece)|October 30, 2024
Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER TrialMakito Miyake, Nobumichi Tanaka, Kenta Ohnishi, et al.
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
International Journal of Urology : Official Journal of the Japanese Urological Association|August 17, 2022
Trends in primary treatment for localized prostate cancer according to the availability of treatment modalities and the impact of introducing robotic surgeryShunta Hori, Yasushi Nakai, Mitsuru Tomizawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2015
Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single instituteMakito Miyake, Daisuke Gotoh, Keiji Shimada, et al.
The Prostate|March 6, 2023
Quality of life in patients who underwent robot-assisted radical prostatectomy compared with those who underwent low-dose-rate brachytherapyYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
Urologia Internationalis|August 25, 2010
Clinical significance of heme oxygenase-1 expression in non-muscle-invasive bladder cancerMakito Miyake, Kiyohide Fujimoto, Satoshi Anai, et al.
Oncology Reports|June 3, 2015
Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinomaKiyohiko Hotta, Masayuki Sho, Kiyohide Fujimoto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 27, 2017
URETHROPLASTY FOR COMPLICATED ANTERIOR URETHRAL STRICTURESKatsuya Aoki, Shunta Hori, Yosuke Morizawa, et al.
IJU Case Reports|August 4, 2020
Localized prostate cancer with pelvic arteriovenous malformation treated with low-dose-rate brachytherapy after transcatheter embolization: Two case reportsTakuya Owari, Nobumichi Tanaka, Yasushi Nakai, et al.
Journal of Cardiology Cases|March 13, 2023
Diffuse alveolar hemorrhage and acute eosinophilic pneumonia: A rare form of amiodarone pulmonary toxicity diagnosed by bronchoalveolar lavageSatoshi Anai, Yuri Nakayama, Hiroki Gushiken, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2021
Trends in risk classification at diagnosis and choice of primary therapy for prostate cancer: An analysis of 10 839 patients from the Nara Urological Research and Treatment Group registry between 2004 and 2015Yasushi Nakai, Nobumichi Tanaka, Tomomi Fujii, et al.
In Vivo (Athens, Greece)|October 30, 2024
Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER TrialMakito Miyake, Nobumichi Tanaka, Kenta Ohnishi, et al.
Pageof 18